See also this year's filing and all EDGAR filings for this company.
PDF Report 0001821586_2024_Moonlake_Immunotherapeutics.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001821586, Moonlake Immunotherapeutics
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 514,167,302 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 320,865 |
| 3 | remainder_Assets | 12,051,948 |
| 4 | LiabilitiesCurrent | 9,965,680 |
| 5 | LiabilitiesNoncurrent | 3,083,416 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,321,216 |
| 9 | ResearchAndDevelopmentExpense | 31,801,880 |
| 10 | remainder_Expenses | 94,388 |
| 11 | remainder_Revenues | 10,138,367 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 9,567,394 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 526,540,115 |
| 1 | Liabilities | 13,049,096 |
| 2 | Expenses | 54,217,484 |
| 3 | Revenues | 10,138,367 |
| 4 | StockholdersEquity | 513,491,019 |
| 5 | NetIncome | -44,079,117 |
| 6 | ComprehensiveNetIncome | -39,295,420 |
| 7 | BaseVar | 306,756,228 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.00 |
| 9 | EconomicCapitalRatio | 4.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
